# Ernexa Therapeutics Inc.: Form S-1/A, filed Feb 4, 2026

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: S-1/A
- Filed: 2026-02-04
- Accepted by EDGAR: Feb 3, 2026, 21:59 ET
- Period: not reported
- Accession: 0001493152-26-004987
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315226004987/forms-1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315226004987/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315226004987/forms-1a.htm

Filed Feb 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-004987. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.